Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device

Investor Relations, Videos

April 18, 2024 12:07 PM

Link to site HERE.

Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025

January 14, 2025

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

December 23, 2024

New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

November 26, 2024